QXL Diagnostics Targets 60 Hospital Laboratory Partnerships by 2028
QXL Diagnostics has announced a strategic growth plan to expand its hospital laboratory partnerships to 60 by 2028. The model aims to help small and mid-sized hospitals access advanced diagnostic capabilities through a managed referral network.
Why it matters
This business model addresses the gap in diagnostic infrastructure for smaller healthcare providers, potentially improving patient care quality.
Bengaluru, Karnataka, India --- Business Wire India
QXL Diagnostics Super Speciality Laboratory, a unit of Qualitify Healthtech Pvt. Ltd. and a doctor-led diagnostic laboratory network headquartered in Bengaluru, today announced a 2028 growth plan centred on Hospital Laboratory Management (HLM), Laboratory Management Services (LMS), lab-to-lab referral testing and super-speciality reference laboratory services.
QXL currently supports 12 hospital laboratory operations in Bengaluru and receives specialised referral investigations from more than 190 hospitals and laboratories. By 2028, the company is targeting 60 hospital laboratory partnerships in Bengaluru and more than 600 lab-to-lab referral partners across Karnataka.
The strategy is designed particularly for small and mid-sized hospitals that need dependable onsite laboratory services while also requiring access to advanced diagnostics, specialist laboratory medicine and structured quality systems without independently maintaining every specialised platform.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in